pubmed-article:20521354 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20521354 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20521354 | lifeskim:mentions | umls-concept:C0920317 | lld:lifeskim |
pubmed-article:20521354 | lifeskim:mentions | umls-concept:C0278726 | lld:lifeskim |
pubmed-article:20521354 | lifeskim:mentions | umls-concept:C0015133 | lld:lifeskim |
pubmed-article:20521354 | lifeskim:mentions | umls-concept:C0032207 | lld:lifeskim |
pubmed-article:20521354 | lifeskim:mentions | umls-concept:C0123931 | lld:lifeskim |
pubmed-article:20521354 | lifeskim:mentions | umls-concept:C0282440 | lld:lifeskim |
pubmed-article:20521354 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:20521354 | pubmed:dateCreated | 2010-6-2 | lld:pubmed |
pubmed-article:20521354 | pubmed:abstractText | To compare the efficacy and toxicities of irinotecan/ platinum (IP) with etoposide/platinum (EP) in patients with previously untreated extensive-stage small cell lung cancer (E-SCLC). | lld:pubmed |
pubmed-article:20521354 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20521354 | pubmed:language | eng | lld:pubmed |
pubmed-article:20521354 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20521354 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20521354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20521354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20521354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20521354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20521354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20521354 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20521354 | pubmed:month | Jun | lld:pubmed |
pubmed-article:20521354 | pubmed:issn | 1556-1380 | lld:pubmed |
pubmed-article:20521354 | pubmed:author | pubmed-author:ZhaohuiChuC | lld:pubmed |
pubmed-article:20521354 | pubmed:author | pubmed-author:JiangJingweiJ | lld:pubmed |
pubmed-article:20521354 | pubmed:author | pubmed-author:HuangLizhenL | lld:pubmed |
pubmed-article:20521354 | pubmed:author | pubmed-author:LiangXiaohuaX | lld:pubmed |
pubmed-article:20521354 | pubmed:author | pubmed-author:ZhouXinliX | lld:pubmed |
pubmed-article:20521354 | pubmed:author | pubmed-author:HuangRuofanR | lld:pubmed |
pubmed-article:20521354 | pubmed:author | pubmed-author:ZhanQiongQ | lld:pubmed |
pubmed-article:20521354 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20521354 | pubmed:volume | 5 | lld:pubmed |
pubmed-article:20521354 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20521354 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20521354 | pubmed:pagination | 867-73 | lld:pubmed |
pubmed-article:20521354 | pubmed:dateRevised | 2011-2-11 | lld:pubmed |
pubmed-article:20521354 | pubmed:meshHeading | pubmed-meshheading:20521354... | lld:pubmed |
pubmed-article:20521354 | pubmed:meshHeading | pubmed-meshheading:20521354... | lld:pubmed |
pubmed-article:20521354 | pubmed:meshHeading | pubmed-meshheading:20521354... | lld:pubmed |
pubmed-article:20521354 | pubmed:meshHeading | pubmed-meshheading:20521354... | lld:pubmed |
pubmed-article:20521354 | pubmed:meshHeading | pubmed-meshheading:20521354... | lld:pubmed |
pubmed-article:20521354 | pubmed:meshHeading | pubmed-meshheading:20521354... | lld:pubmed |
pubmed-article:20521354 | pubmed:meshHeading | pubmed-meshheading:20521354... | lld:pubmed |
pubmed-article:20521354 | pubmed:meshHeading | pubmed-meshheading:20521354... | lld:pubmed |
pubmed-article:20521354 | pubmed:meshHeading | pubmed-meshheading:20521354... | lld:pubmed |
pubmed-article:20521354 | pubmed:meshHeading | pubmed-meshheading:20521354... | lld:pubmed |
pubmed-article:20521354 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20521354 | pubmed:articleTitle | A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. | lld:pubmed |
pubmed-article:20521354 | pubmed:affiliation | Department of Oncology, Huashan Hospital, Fudan University, Shanghai, China. | lld:pubmed |
pubmed-article:20521354 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20521354 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:20521354 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:20521354 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20521354 | lld:pubmed |